Human β-tryptase: Detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors

Biochemistry

Volumn 43, Issue 33, 2004, Pages 10757-10764

  Fukuoka, Yoshihiro ^a   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDS; BIOCHEMISTRY; CONCENTRATION (PROCESS); MONOMERS; PH; SUBSTRATES;

GRANULES; SERINE PROTEASES; TETRAMER;

ENZYMES;

ALPHA 2 MACROGLOBULIN; ANTITHROMBIN III; APROTININ; BETA TRYPTASE; DEXTRAN SULFATE; HEPARIN; MONOMER; POLYANION; PROTEINASE INHIBITOR; SERINE PROTEINASE; SOYBEAN TRYPSIN INHIBITOR; TETRAMER; TRYPTASE; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CONCENTRATION RESPONSE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; INHIBITION KINETICS; MAST CELL; PH MEASUREMENT; PRIORITY JOURNAL; PROTEINASE INHIBITION; SECRETORY GRANULE; VASCULARIZATION;

ALPHA-MACROGLOBULINS; ANTITHROMBIN III; DIMERIZATION; ENZYME ACTIVATION; HEPARIN; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; OLIGOPEPTIDES; POLYMERS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; TRYPTASES;

BOVINAE; GLYCINE MAX;

EID: 4143123236     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049486c     Document Type: Article

References (20)

1. Schwartz, L. B. (2002) Mast cells and basophils, in Inflammatory Mechanisms in Allergic Diseases (Zweiman, B., and Schwartz, L. B., Eds.) pp 3-42, Marcel Dekker, New York.
2. Goldstein, S. M., Leong, J., Schwartz, L. B., and Cooke, D. (1992) Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes: Tryptase resides in a complex distinct from chymase and carboxypeptidase, J. Immunol. 148, 2475-2482.
3. Schwartz, L. B., and Bradford, T. R. (1986) Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer, J. Biol. Chem. 261, 7372-7379.
4. Schwartz, L. B., Lewis, R. A., and Austen, K. F. (1981) Tryptase from human pulmonary mast cells. Purification and characterization, J. Biol. Chem. 256, 11939-11943.
5. Pereira, P. J., Bergner, A., Macedo-Ribeiro, S., Huber, R., Matschiner, G., Fritz, H., Sommerhoff, C. P., and Bode, W. (1998) Human β-tryptase is a ring-like tetramer with active sites facing a central pore, Nature 392, 306-311.
6. Sommerhoff, C. P., Bode, W., Pereira, P. J., Stubbs, M. T., Sturzebecher, J., Piechottka, G. P., Matschiner, G., and Bergner, A. (1999) The structure of the human betaII-tryptase tetramer: fo(u)r better or worse, Proc. Natl. Acad. Sci. U.S.A. 96, 10984-10991.
7. Sakai, K., Ren, S., and Schwartz, L. B. (1996) A novel heparin-dependent processing pathway for human tryptase: autocatalysis followed by activation with dipeptidyl peptidase I, J. Clin. Invest. 97, 988-995.
8. Schechter, N. M., Eng, G. Y., and McCaslin, D. R. (1993) Human skin tryptase: Kinetic characterization of its spontaneous inactivation, Biochemistry 32, 2617-2625.
9. Addington, A. K., and Johnson, D. A. (1996) Inactivation of human lung tryptase: Evidence for a re-activatable tetrameric intermediate and active monomers, Biochemistry 35, 13511-13518.
10. Ren, S. L., Sakai, K., and Schwartz, L. B. (1998) Regulation of human mast cell β-tryptase: Conversion of inactive monomer to active tetramer at acid pH, J. Immunol. 160, 4561-4569.
11. Ren, S., Lawson, A. E., Carr, M., Baumgarten, C. M., and Schwartz, L. B. (1997) Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12, J. Immunol. 159, 3540-3548.
12. Hallgren, J., Spillmann, D., and Pejler, G. (2001) Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin, J. Biol. Chem. 276, 42774-42781.
13. Fajardo, I., and Pejler, G. (2003) Formation of active monomers from tetrameric human beta-tryptase, Biochem. J. 369, 603-610.
14. Schwartz, L. B., Bradford, T. R., Lee, D. C., and Chlebowski, J. F. (1990) Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer: Production of monoclonal antibodies recognizing active tryptase, J. Immunol. 144, 2304-2311.
15. Sakai, K., Long, S. D., Pettit, D. A. D., Cabral, G. A., and Schwartz, L. B. (1996) Expression and purification of recombinant human tryptase in a baculovirus system, Protein Expression Purif. 7, 67-73.
16. Schwartz, L. B., Bradford, T. R., Rouse, C., Irani, A.-M., Rasp, G., Van der Zwan, J. K., and Van Der Linden, P.-W. G. (1994) Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis, J. Clin. Immunol. 14, 190-204.
17. Alter, S. C., Metcalfe, D. D., Bradford, T. R., and Schwartz, L. B. (1987) Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides, Biochem. J. 248, 821-827.
18. Bjork, I., Jackson, C. M., Jornvall, H., Lavine, K. K., Nordling, K., and Salsgiver, W. J. (1982) The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin, J. Biol. Chem. 257, 2406-2411.
19. Austin, R. C., Sheffield, W. P., Rachubinski, R. A., and Blajchman, M. A. (1992) The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin, Biochem. J. 282, 345-351.
20. Harpel, P. C. (1973) Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure, J. Exp. Med. 138, 508-521.